Prevention and Treatment of Thromboembolic Events in Patients with Cancer: Advances and Challenges
Am J Respir Crit Care Med
.
2020 Jul 1;202(1):124-127.
doi: 10.1164/rccm.201909-1782RR.
Authors
Marie-Hélène Denault
1
,
Louis-Vincent Morin-Thibault
1
,
Sophie B Kermelly
1
,
Catherine Labbé
1
Affiliation
1
Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Quebec, Canada.
PMID:
32392427
DOI:
10.1164/rccm.201909-1782RR
No abstract available
Publication types
Comment
MeSH terms
Factor Xa Inhibitors
Heparin, Low-Molecular-Weight
Humans
Neoplasms*
Venous Thromboembolism*
Substances
Factor Xa Inhibitors
Heparin, Low-Molecular-Weight